Filing Details

Accession Number:
0001209191-11-057409
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-21 17:22:36
Reporting Period:
2011-11-18
Filing Date:
2011-11-21
Accepted Time:
2011-11-21 17:22:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP.OB Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412377 Marc Rubin 400 Oyster Point Blvd., Suite 505
So. San Francisco CA 94080
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Per Share Acquisiton 2011-11-18 38,400 $1.27 413,400 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct